Apply to Join
 Health  Russia Project #9795

Help Children with Cancer Access Treatment!

by Advita Fund USA
Help Children with Cancer Access Treatment!
Jun 20, 2019

Rodion needs our help!

Rodion
Rodion

One of our latest support recipients is Rodion, a 14-year old from Odessa, Ukraine. In January 2018 he began feeling unwell – and his family was shocked when he was diagnosed with acute lymphoblastic leukemia. At first, he was treated at the local Children’s Clinical Hospital, but without success as he did not achieve complete remission. Rodion’s diagnosis was then graded as High-Risk disease. Due to poor level of oncology in Ukraine, Rodion’s family decided to continue treatment abroad in a Center for Pediatric Oncology, Hematology and Immunology in Belarus and pay for it out of their own means. The treatment in the Center had lasted for 8 months (from February to October 2018) and finally Rodion was discharged in complete remission to continue maintenance therapy at home.

On December 19, 2018, just two months later, the disease relapsed. Due to very early relapse Rodion has a chance to survive through transplantation of donor’s bone marrow only. However, to proceed with transplantation, he has to achieve complete remission again, and the family brought Rodion back to Belarus for chemotherapy.  Unfortunately, high-dose chemotherapy was not effective due to acquired resistance to treatment. In this situation, a very expensive new immunotherapy drug, blinatumomab (Blincyto) was recommended as only remaining way to reach remission. This type of immunotherapy was unavailable in Belarus.

The family urgently transferred Rodion to Medipol Mega Hospital in Istambul, Turkey, as it was the nearest place where the therapy was available and it had no entry visa requirements. The treatment cost was taken into consideration as well. The Medipol Mega Hospital billed Rodion’s family $130,000 for 2 courses of Blincito immunotherapy. The first course of immunotherapy was completed in February – March 2019. Rodion did not tolerate it well and had many negative side effects which resulted an additional rehabilitation period in the hospital that increased treatment cost. But more important was improvement observed after first course of immunotherapy and that filled Rodion’s family with faith and hope. Second course of immunotherapy started in April. However, by then Rodion’s family already spent all their savings as well as financial support from their relatives and friends. Currently, their financial resources are completely exhausted and they are seeking help to ensure Rodion can complete his treatment.  

We are very grateful to you for your support of kids like Rodion and their families struggling to do everything possible to save them.  Thank you for your kindness and care!  

Comments:

About Project Reports

Project Reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.

If you donate to this project or have donated to this project, you will get an e-mail when this project posts a report. You can also subscribe for reports via e-mail without donating.

Get Reports via Email

We'll only email you new reports and updates about this project.

Organization Information

Advita Fund USA

Location: Houston, Texas - USA
Website:
Facebook: Facebook Page
Twitter: @advitausa
Project Leader:
Marina Ouano
President
Houston, Texas United States
* This project is competing for bonus prizes
through the Year End Campaign 2019. Terms and conditions apply.

Learn more about GlobalGiving

Teenage Science Students
Vetting +
Due Diligence

Snorkeler
Our
Impact

Woman Holding a Gift Card
Give
Gift Cards

Young Girl with a Bicycle
GlobalGiving
Guarantee

Sign up for the GlobalGiving Newsletter

WARNING: Javascript is currently disabled or is not available in your browser. GlobalGiving makes extensive use of Javascript and will not function properly with Javascript disabled. Please enable Javascript and refresh this page.